BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19614558)

  • 1. A new step toward individualized antifungal prevention in hematopoietic stem cell transplantation.
    Bochud PY; Calandra T
    Clin Infect Dis; 2009 Sep; 49(5):733-5. PubMed ID: 19614558
    [No Abstract]   [Full Text] [Related]  

  • 2. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
    Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
    Lehrnbecher T; Mousset S; Sörensen J; Böhme A
    Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated.
    Yokoe D; Casper C; Dubberke E; Lee G; Muñoz P; Palmore T; Sepkowitz K; Young JA; Donnelly JP; ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):495-507. PubMed ID: 19861984
    [No Abstract]   [Full Text] [Related]  

  • 6. Safe living after hematopoietic cell transplantation.
    Yokoe D; Casper C; Dubberke E; Lee G; Muñoz P; Palmore T; Sepkowitz K; Young JA; Donnelly JP; ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):509-19. PubMed ID: 19861985
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective.
    ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):453-558. PubMed ID: 20095071
    [No Abstract]   [Full Text] [Related]  

  • 8. Current world literature. Infections of the immunocompromised host.
    Curr Opin Infect Dis; 2003 Dec; 16(6):636-9. PubMed ID: 15043067
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term care after hematopoietic-cell transplantation in adults.
    Boeckh M; Nichols WG; Marr KA
    N Engl J Med; 2002 Nov; 347(20):1625-6; author reply 1625-6. PubMed ID: 12432056
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination of hematopoietic cell transplant recipients.
    Ljungman P; Cordonnier C; Einsele H; Englund J; Machado CM; Storek J; Small T; ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):521-6. PubMed ID: 19861986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fungal infection in hematopoietic stem cell transplantation].
    Taniguchi S
    Rinsho Ketsueki; 2008 Oct; 49(10):1349-57. PubMed ID: 18833919
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.
    Tomblyn M; Chiller T; Einsele H; Gress R; Sepkowitz K; Storek J; Wingard JR; Young JA; Boeckh MJ
    Bone Marrow Transplant; 2009 Oct; 44(8):453-5. PubMed ID: 19861977
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
    Camps IR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.
    Safdar A
    Bone Marrow Transplant; 2006 Sep; 38(5):327-37. PubMed ID: 16915223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.
    Slavin MA; Heath CH; Thursky KA; Morrissey CO; Szer J; Ling LM; Milliken ST; Grigg AP
    Intern Med J; 2008 Jun; 38(6b):468-76. PubMed ID: 18588520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and fungal infections.
    Antachopoulos C; Roilides E
    Br J Haematol; 2005 Jun; 129(5):583-96. PubMed ID: 15916680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of antifungal prophylaxis in opportunistic mycoses].
    Torres-Rodríguez JM
    Enferm Infecc Microbiol Clin; 1996 Jan; 14(1):44-53. PubMed ID: 8714187
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal Innate Immunity: A Perspective from the Last 10 Years.
    Salazar F; Brown GD
    J Innate Immun; 2018; 10(5-6):373-397. PubMed ID: 29768268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal use of the newer antifungal agents.
    Helwick C
    Oncology (Williston Park); 2000 Sep; 14(9):1262-4. PubMed ID: 11033823
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
    Chandrasekar P; Ljungman PT
    Transplantation; 2008 Jul; 86(2):183-91. PubMed ID: 18645475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.